General Information of the Compound
| Compound ID |
CP0485068
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-((naphthalen-2-yloxy)methyl)piperidine
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-((naphthalen-2-yloxy)methyl)piperidine
4-[(2-Naphthyloxy)methyl]piperidine
4-[(naphthalen-2-yloxy)methyl]piperidine
946680-75-7
AKOS000172158
BDBM50278526
CHEMBL453996
CTK7D1529
ZINC14631494
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H19NO
|
||||||||||||||||||
| Molecular Weight |
241.334
|
||||||||||||||||||
| Canonical SMILES |
C(Oc1ccc2ccccc2c1)C1CCNCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H19NO/c1-2-4-15-11-16(6-5-14(15)3-1)18-12-13-7-9-17-10-8-13/h1-6,11,13,17H,7-10,12H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
MUOXAGUZMVATIC-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02227, 5-hydroxytryptamine receptor 3A
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Clinical Information about the Compound